Communiqués ANGLE plc

Actions

AGL

GB0034330679

Marché Fermé - London S.E. Autres places de cotation 17:35:27 27/06/2024			Varia. 5j.	Varia. 1 janv.
13,75 ^GBX	0,00%		-3,51%	+17,02%

21/06	Angle plc lève des fonds par le biais d'une offre ouverte d'actions	MT
21/06	Angle annonce que l'offre ouverte a permis de lever 500 000 GBP	AN

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

ANGLE : Annual Report December 2023	18/06	PU
ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant	08/05	AQ
ANGLE PLC - NEW COMMERCIAL AGREEMENT WITH LARGE PHARMA	06/05	AQ
ANGLE partners with AstraZeneca in groundbreaking oncology contract	24/04	AQ
ANGLE PLC - US AND EU PATENTS FOR ANGLE'S INNOVATIVE CELLKEEP SLIDE	23/04	AQ
ANGLE achieves breakthrough with EU patent for CellKeep technology, with the US to follow	23/04	AQ
ANGLE PLC - PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE	09/04	AQ
ANGLE PLC - REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY	25/03	AQ
ANGLE PLC - PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCE	25/03	AQ
ANGLE PLC - REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UTILITY IN PRECISION ONCOLOGY	23/01	AQ
ANGLE PLC - BREAKTHROUGH CLINICAL RESULTS PROVIDE A UNIQUE INSIGHT INTO THE PROGRESSION OF EACH PATIENT'S CANCER	05/01	AQ
ANGLE LAUNCHES PORTRAIT+ CTC KIT AT SAN ANTONIO BREAST CANCER SYMPOSIUM	06/12	AQ
ANGLE LAUNCHES PD-L1 TEST TO SUPPORT CANCER THERAPY STUDIES	10/11	AQ
ANGLE PLC - TRADING AND BUSINESS UPDATE	10/11	AQ
ANGLE PLC - RESEARCH DEMONSTRATES POTENTIAL OF THE PARSORTIX SYSTEM TO SUPPORT POWERFUL CHARACTERISATION OF CTCS IN HEAD AND NECK CANCER	26/10/23	AQ
ANGLE PLC - PARSORTIX SYSTEM OUTPERFORMS CURRENT LABORATORY STANDARD FOR DISSEMINATED TUMOUR CELL HARVEST	04/10/23	AQ
Angle Plc - Launch of Portrait Flex Circulating Tumor Cell Assay	05/09/23	AQ
ANGLE : Annual Report December 2022	26/05/23	PU
ANGLE PLC has opened up "a major market opportunity" with breast cancer partnership	20/04/23	AQ
ANGLE : Interim Report June 2022	14/11/22	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués ANGLE plc

Actions

AGL

GB0034330679

Communiqués

Filtres